Alert: Post-Ban Fallout in Kansas and Tennessee Highlights Sustained Compliance Risks

Fallout from the July 1 kratom bans in Kansas and Tennessee continues to demonstrate the destabilizing effects of prohibition. In Kansas, the classification of kratom and 7-hydroxymitragynine (7-OH) as Schedule I substances prompted public health organizations like DCCCA to launch extensive public health campaigns and clinical toolkits to prepare providers for forced withdrawals. The Kansas Hospital Association warned of increased patient withdrawals and potential overdoses from substance switching.

Similarly, in Tennessee, treatment centers like Freeman Recovery Center rapidly expanded dual-diagnosis evaluations and medical detox capacity due to daily kratom and 7-OH consumers being forced into withdrawal without tapering. Clinicians reported patients 'hitting physical boundaries rapidly,' with concerns about individuals turning to unregulated gray-market kratom or more potent opioids. Anecdotal reports from healthcare workers highlight the unpreparedness of the state to handle the surge in detox cases, with patients experiencing severe withdrawal symptoms.

Restoration Recovery, operating in Southeast Tennessee and North Georgia, documented a direct rise in Medication-Assisted Treatment (MAT) requests from patients seeking safe transitions post-July 1, noting a behavioral shift of Tennessee residents driving across state lines. This ongoing fallout underscores the critical need for merchants to adhere strictly to state-specific legal statuses to mitigate compliance, payment processing, and shipping risks.

Source: Kratom Science via Sentinel Newsroom